analyst
ZB
NASDAQ · ZBIO
Zenas BioPharma, Inc.
Healthcare · Biotechnology
$31.10
Up+$0.20 (+0.65%)
Updated Sep 11, 2026, 5:06 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.69B
- P/E ratio
- -9.52
- Dividend yield
- 0.00%
- 52-week range
- $16.41 – $34.05
- Volume
- 646.94K
- Avg. volume
- 419.1K
Price performance
ZBIO price history
1M range · 20 trading sessions · Daily adjusted prices
ZBIO closed at $31.10 after 20 trading sessions, up 6.51% for the selected period.
- Last close
- $31.10
- Period change
- +6.51%
- Period low
- $29.20
- Period high
- $33.77
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $31.88 | $31.89 | $30.73 | $31.10 | 646.94K |
| Sep 9, 2026 | $33.02 | $33.525 | $32.085 | $32.29 | 385.38K |
| Sep 8, 2026 | $32.65 | $33.84 | $32.305 | $33.05 | 441.2K |
| Sep 4, 2026 | $32.66 | $33.29 | $32.381 | $32.88 | 452.69K |
| Sep 3, 2026 | $33.42 | $33.66 | $32.365 | $32.92 | 515.12K |
| Sep 2, 2026 | $32.21 | $33.395 | $31.93 | $33.13 | 757.49K |
| Sep 1, 2026 | $32.20 | $32.73 | $31.55 | $31.98 | 432.25K |
| Aug 31, 2026 | $31.51 | $32.77 | $29.88 | $32.32 | 527.68K |
| Aug 28, 2026 | $32.27 | $32.38 | $31.19 | $31.27 | 439.14K |
| Aug 27, 2026 | $32.81 | $33.69 | $32.38 | $32.62 | 658.97K |
| Aug 26, 2026 | $33.80 | $33.99 | $31.91 | $33.04 | 651.58K |
| Aug 25, 2026 | $32.00 | $33.78 | $31.645 | $33.77 | 633.58K |
| Aug 24, 2026 | $32.40 | $32.48 | $30.95 | $31.65 | 481.88K |
| Aug 21, 2026 | $31.83 | $32.79 | $31.45 | $32.29 | 808.72K |
| Aug 20, 2026 | $30.72 | $32.20 | $29.50 | $31.62 | 1.17M |
| Aug 19, 2026 | $32.80 | $32.8899 | $30.92 | $31.25 | 2.7M |
| Aug 18, 2026 | $30.22 | $31.96 | $30.22 | $31.91 | 659.82K |
| Aug 17, 2026 | $29.95 | $30.81 | $28.72 | $30.50 | 490.11K |
| Aug 14, 2026 | $28.76 | $30.31 | $28.163 | $29.51 | 630.04K |
| Aug 13, 2026 | $30.39 | $31.00 | $27.81 | $29.20 | 881.51K |
Latest ZBIO news
The latest Smart Investors Daily articles mentioning ZBIO.
Stock researchResearch & News · SEC Filings
Loading stock research…